Botulinum toxin for the treatment of spasmodic dysphonia

Citation
Sr. Gibbs et A. Blitzer, Botulinum toxin for the treatment of spasmodic dysphonia, OTOLAR CLIN, 33(4), 2000, pp. 879
Citations number
37
Categorie Soggetti
Otolaryngology
Journal title
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA
ISSN journal
00306665 → ACNP
Volume
33
Issue
4
Year of publication
2000
Database
ISI
SICI code
0030-6665(200008)33:4<879:BTFTTO>2.0.ZU;2-4
Abstract
Spasmodic dysphonia is a focal laryngeal dystonia. Laryngeal dystonia prese nts as: adductor spasmodic dysphonia with the characteristic strain-strangl e voice; abductor spasmodic dysphonia with hypophonia and breathy breaks in connected speech; and adductor respiratory dystonia with paradoxical vocal fold motion and intermittent strider. Current treatment with periodic lary ngeal intramuscular injections of botulinum toxin A has allowed patients to function more normally. In this article, the authors' treatment paradigm a nd experience in treating over 900 patients with laryngeal dystonia are dis cussed.